OPKO Health to Present at the Jefferies 2011 Global Healthcare Conference

MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE Amex: OPK) today announced that senior management will present at the Jefferies 2011 Global Healthcare Conference on Tuesday, June 7, 2011 at 1:15 PM Eastern Time in New York, NY.

OPKO senior management will provide a review of recent corporate developments.

About OPKO Health, Inc.

Miami-based OPKO is a specialty healthcare company involved in the discovery, development, and commercialization of proprietary pharmaceutical and diagnostic products and vaccines. Initially focused on the treatment and management of ophthalmic diseases, OPKO has since expanded into other areas of major unmet medical need.



CONTACT:

OPKO Health, Inc.
Steven D. Rubin, 305 575-6015

KEYWORDS:   United States  North America  Florida

INDUSTRY KEYWORDS:   Health  Biotechnology  Genetics  Infectious Diseases  Medical Devices  Oncology  Optical  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Combining inhibitors of KRAS-G12C, mTOR and IGF1R can significantly shrink lung tumors in mice and human cancer cells, a study found.

X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, who founded the company alongside CEO Paula Ragan and biotech luminary Henri Termeer.

Henlius Biotech missed the $477 million goal it set for its IPO, but still made the top five biopharma IPOs this year with its $410 million listing.